Q1 FY27 snapshot
Announcement Date4-Aug-26
Revenue (Top Line)₹2,150 Cr
Net Profit (Bottom Line)₹172 Cr
Earnings Per Share (EPS)₹8.8
Expenses₹1,818 Cr
Net profit margin (calculated)8%
Alembic Pharmaceuticals Ltd. (APLLTD) Quarterly Results: Q1 FY27
Quick answer: Alembic Pharmaceuticals Ltd. (NSE: APLLTD) reported Q1 FY27 revenue of ₹2,150 Cr and net profit of ₹172 Cr, with earnings per share (EPS) of ₹8.8, announced on 4-Aug-26.
That works out to a net profit margin of about 8% for the quarter.
Note: figures are pulled automatically from company filings and may lag or contain gaps. Verify on NSE or BSE. Not investment advice.
How to read Alembic Pharmaceuticals Ltd.'s Q1 FY27 results
Revenue of ₹2,150 Cr is what Alembic Pharmaceuticals Ltd. earned before costs. Net profit of ₹172 Cr is what remained for shareholders after expenses, interest and tax. Dividing one by the other gives a net margin of about 8%, a quick gauge of how much of each rupee of sales is kept as profit.
New to results? Read our guide on how to read quarterly results, see the full results list or the dividend calendar.
FAQs
Alembic Pharmaceuticals Ltd. results FAQs
What were Alembic Pharmaceuticals Ltd.'s Q1 FY27 results?
Alembic Pharmaceuticals Ltd. (NSE: APLLTD) reported Q1 FY27 revenue of ₹2,150 Cr and net profit of ₹172 Cr, with earnings per share (EPS) of ₹8.8, announced on 4-Aug-26.
What is Alembic Pharmaceuticals Ltd.'s EPS for Q1 FY27?
Alembic Pharmaceuticals Ltd.'s earnings per share for Q1 FY27 was ₹8.8. EPS is net profit divided by the number of outstanding shares.
When did Alembic Pharmaceuticals Ltd. announce its Q1 FY27 results?
Alembic Pharmaceuticals Ltd. announced its Q1 FY27 results on 4-Aug-26.
What is Alembic Pharmaceuticals Ltd.'s net profit margin?
On the reported figures, Alembic Pharmaceuticals Ltd.'s Q1 FY27 net profit margin is about 8% (net profit ÷ revenue).